Fundamental dimension Equity attribute | BGSLeader $2.10▼-2.33% Cap $170.7MP/E -2.4x QuantScore36/100 | ABVEPeer $0.0301▼-49.83% Cap $1.54MP/E -0.0x QuantScore30/100 | BRCCPeer $11.30▲+1.71% Cap $359.5MP/E -33.7x QuantScore31/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
23/100 |
74/100 |
Valuation Multiples, PEG & DCF upside | 76/100 | 75/100 | 7/100 |
Health Piotroski, Altman Z, leverage & liquidity | 13/100 | 23/100 | 34/100 |
Growth Revenue / earnings growth & margins | 21/100 | 0/100 | 21/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | — | 20/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.4x | -0.0x | -33.7x |
Forward P/E (next FY) | 3.8x | — | 61.1x |
EV / EBITDA (TTM) | 14.9x | -3.1x | 70.8x |
Price / Sales | 0.1x | 0.0x | 0.8x |
Price / Free Cash Flow | 2.7x | 0.6x | 46.8x |
PEG ratio | 0.04 | 0.00 | -0.28 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 6 / 9 |
Altman Z-Score | 0.95 (Distress) | -2.71 (Distress) | 2.91 (Grey) |
Total debt / equity | 6.52 | -2.54 | 1.19 |
Quick ratio | 1.1x | 0.3x | 0.8x |
Interest coverage | 0.4x | -5.5x | -0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -5.4% | -7.1% | +1.7% |
Net income growth YoY | +82.8% | -17.2% | -303.6% |
Gross margin (TTM) | 21.5% | -1.6% | 33.9% |
Operating margin (FY) | 5.3% | -11.4% | -6.2% |
FCF margin (FY) | 3.9% | 0.9% | -3.4% |
5. Trailing price performancePrice change over period |
1M return | -30.5% | -49.8% | +25.0% |
3M return | -40.2% | -94.0% | +4.6% |
6M return | -60.7% | -97.8% | -2.6% |
Year to date | -51.2% | -98.2% | +1.8% |
1Y return | -53.0% | -98.4% | -19.3% |
3Y return | -74.9% | -99.7% | -58.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $12.05 +473.8% upside | $733.15 +2435608.4% upside | $-99.23 -978.1% premium |
Wall Street consensus target | $3.83 +82.4% · range $3.00–$4.50 | — — | $1.75 -84.5% · range $1.75–$1.75 |
Consensus stance | 18% Buy65% Hold18% Sell | — | 36% Buy64% Hold0% Sell |